EMED Technologies focuses on innovative subcutaneous infusion and drug delivery solutions designed to enable independence for patients at home. The company develops infusion systems and devices tailored for biologics and specialty drugs, aimed at improving safety, comfort, and ease of use in at-home treatment. With a global presence, EMED provides end-to-end services from device development to manufacturing and partnerships that advance patient care in subcutaneous therapies.
No recent news for this company.